From: Assessment of plasminogen activator inhibitor-1 in obese Egyptian children
Anthropometric data | MetS (no. = 12) | Non-MetS (no. = 31) | p value |
---|---|---|---|
Height (SDS) | 0.523 ± 0.971 | 0.325 ± 1.42 | 0.6 |
Weight (SDS) | 3.41 ± 1.70 | 3.06 ± 1.47 | 0.5 |
BMI (kg/m2) | 30.15 ± 3.29 | 29.15 ± 3.55 | 0.4 |
BMI (SDS) | 3.23 ± 0.733 | 3.08 ± 0.560 | 0.5 |
Waist circumference (cm) | 89.61 ± 9.16 | 85.21 ± 4.21 | 0.03* |
Hip circumference (cm) | 95.29 ± 10.48 | 90.96 ± 7.58 | 0.2 |
W/H ratio | 0.939 ± 0.052 | 0.934 ± 0.054 | 0.8 |
Biceps skin fold (mm) | 19.07 ± 5.32 | 18.75 ± 2.99 | 0.8 |
Triceps skin fold (mm) | 26.23 ± 5.23 | 25.00 ± 3.28 | 0.5 |
Subscapular skin fold (mm) | 25.25 ± 3.67 | 26.48 ± 5.46 | 0.5 |
Systolic Bp (mmHg) | 121.42 ± 6.29 | 112.90 ± 8.92 | 0.001* |
Diastolic Bp (mmHg) | 82.92 ± 12.15 | 75.81 ± 10.89 | 0.04* |
Total cholesterol (mg/dl) | 171.94 ± 26.06 | 159.25 ± 33.32 | 0.2 |
Triglycerides (mg/dl) | 125.83 ± 32.86 | 90.71 ± 21.92 | 0.000** |
HDL-c (mg/dl) | 40.08 ± 13.53 | 41.68 ± 9.87 | 0.8 |
LDL-c (mg/dl) | 89.75 ± 43.91 | 108.19 ± 25.78 | 0.2 |
FBS (mg/dl) | 103.08 ± 4.36 | 91.00 ± 8.80 | 0.000** |
Insulin (μIU/ml) | 19.31 ± 7.40 | 17.15 ± 8.35 | 0.4 |
HOMA-IR | 4.89 ± 1.85 | 3.85 ± 1.93 | 0.1 |
PAI-1 | 55.67 ± 4.94 | 49.84 ± 4.52 | 0.02 |